Packaged Foods
Build Your Comparison
Side-by-side financial analysisStock Comparison
NCRA vs RELI vs JPM vs KO vs BAC
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Brokers
Banks - Diversified
Beverages - Non-Alcoholic
Banks - Diversified
NCRA vs RELI vs JPM vs KO vs BAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Insurance - Brokers | Banks - Diversified | Beverages - Non-Alcoholic | Banks - Diversified |
| Market Cap | $2M | $554K | $842.21B | $342.09B | $409.69B |
| Revenue (TTM) | $11M | $13M | $270.79B | $49.28B | $188.75B |
| Net Income (TTM) | $-4M | $-7M | $58.03B | $13.70B | $30.63B |
| Gross Margin | 1.4% | -14.5% | 58.6% | 61.7% | 55.4% |
| Operating Margin | -25.2% | -66.3% | 27.7% | 29.3% | 18.5% |
| Forward P/E | — | — | 14.0x | 24.3x | 12.1x |
| Total Debt | $7M | $13M | $751.15B | $45.49B | $365.90B |
| Cash & Equiv. | $8M | $373K | $469.32B | $10.27B | $231.84B |
NCRA vs RELI vs JPM vs KO vs BAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | Jun 26 | Return |
|---|---|---|---|
| Nocera, Inc. (NCRA) | 100 | 3.7 | -96.3% |
| Reliance Global Gro… (RELI) | 100 | 0.0 | -100.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 242.8 | +142.8% |
| The Coca-Cola Compa… (KO) | 100 | 165.1 | +65.1% |
| Bank of America Cor… (BAC) | 100 | 181.6 | +81.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NCRA vs RELI vs JPM vs KO vs BAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NCRA lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, RELI doesn't own a clear edge in any measured category.
JPM ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 14.6%, EPS growth 21.7%
- 435.6% 10Y total return vs BAC's 323.5%
- NIM 2.3% vs BAC's 1.8%
- 14.6% NII/revenue growth vs NCRA's -35.2%
KO carries the broadest edge in this set and is the clearest fit for quality and dividends.
- 27.8% margin vs RELI's -53.4%
- 2.6% yield, 56-year raise streak, vs JPM's 1.6%, (2 stocks pay no dividend)
- 13.1% ROA vs NCRA's -52.5%, ROIC 15.8% vs -70.0%
BAC is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 12 yrs, beta 0.89, yield 2.4%
- Lower volatility, beta 0.89, current ratio 0.42x
- PEG 0.79 vs KO's 2.18
- Beta 0.89, yield 2.4%, current ratio 0.42x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.6% NII/revenue growth vs NCRA's -35.2% | |
| Value | Lower P/E (12.1x vs 24.3x), PEG 0.79 vs 2.18 | |
| Quality / Margins | 27.8% margin vs RELI's -53.4% | |
| Stability / Safety | Beta 0.89 vs NCRA's 1.68, lower leverage | |
| Dividends | 2.6% yield, 56-year raise streak, vs JPM's 1.6%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +24.4% vs NCRA's -83.7% | |
| Efficiency (ROA) | 13.1% ROA vs NCRA's -52.5%, ROIC 15.8% vs -70.0% |
NCRA vs RELI vs JPM vs KO vs BAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NCRA vs RELI vs JPM vs KO vs BAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 4 of 6 categories
BAC leads 1 • JPM leads 1 • NCRA leads 0 • RELI leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $270.8B annually — 23812.7x NCRA's $11M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to RELI's -53.4%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $11M | $13M | $270.8B | $49.3B | $188.8B |
| EBITDAEarnings before interest/tax | -$3M | -$7M | $81.3B | $15.5B | $36.6B |
| Net IncomeAfter-tax profit | -$4M | -$7M | $58.0B | $13.7B | $30.6B |
| Free Cash FlowCash after capex | -$3M | -$2M | -$119.7B | $12.6B | $12.6B |
| Gross MarginGross profit ÷ Revenue | +1.4% | -14.5% | +58.6% | +61.7% | +55.4% |
| Operating MarginEBIT ÷ Revenue | -25.2% | -66.3% | +27.7% | +29.3% | +18.5% |
| Net MarginNet income ÷ Revenue | -34.0% | -53.4% | +21.6% | +27.8% | +16.2% |
| FCF MarginFCF ÷ Revenue | -26.9% | -18.1% | -15.5% | +25.5% | +6.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -49.8% | -27.5% | — | +12.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -3.9% | +70.1% | +16.0% | +18.2% | +18.3% |
Valuation Metrics
BAC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 14.1x trailing earnings, BAC trades at a 46% valuation discount to KO's 26.1x P/E. Adjusting for growth (PEG ratio), BAC offers better value at 0.92x vs KO's 2.34x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2M | $553,552 | $842.2B | $342.1B | $409.7B |
| Enterprise ValueMkt cap + debt − cash | $2M | $13M | $1.12T | $377.3B | $543.8B |
| Trailing P/EPrice ÷ TTM EPS | -0.84x | -0.03x | 15.82x | 26.14x | 14.09x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 14.03x | 24.31x | 12.07x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.22x | 2.34x | 0.92x |
| EV / EBITDAEnterprise value multiple | — | — | 13.54x | 25.47x | 14.85x |
| Price / SalesMarket cap ÷ Revenue | 0.22x | 0.04x | 3.11x | 7.14x | 2.17x |
| Price / BookPrice ÷ Book value/share | 1.09x | 0.08x | 2.61x | 10.00x | 1.34x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 64.59x | 32.48x |
Profitability & Efficiency
KO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-181 for RELI. BAC carries lower financial leverage with a 1.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to RELI's 4.35x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs NCRA's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -132.0% | -181.4% | +16.1% | +41.1% | +10.1% |
| ROA (TTM)Return on assets | -52.5% | -41.3% | +1.3% | +13.1% | +0.9% |
| ROICReturn on invested capital | -70.0% | -32.0% | +5.4% | +15.8% | +3.2% |
| ROCEReturn on capital employed | -35.9% | -45.9% | +8.2% | +17.3% | +4.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 5 | 7 | 7 |
| Debt / EquityFinancial leverage | 3.31x | 4.35x | 2.18x | 1.33x | 1.21x |
| Net DebtTotal debt minus cash | -$697,307 | $13M | $281.8B | $35.2B | $134.1B |
| Cash & Equiv.Liquid assets | $8M | $372,695 | $469.3B | $10.3B | $231.8B |
| Total DebtShort + long-term debt | $7M | $13M | $751.1B | $45.5B | $365.9B |
| Interest CoverageEBIT ÷ Interest expense | — | -4.90x | 0.74x | 10.70x | 0.44x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $20,251 today (with dividends reinvested), compared to $3 for RELI. Over the past 12 months, BAC leads with a +24.4% total return vs NCRA's -83.7%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.0% vs RELI's -84.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -80.3% | -54.3% | -3.1% | +15.8% | -2.8% |
| 1-Year ReturnPast 12 months | -83.7% | -81.7% | +21.5% | +15.0% | +24.4% |
| 3-Year ReturnCumulative with dividends | -88.7% | -99.6% | +135.5% | +40.5% | +99.5% |
| 5-Year ReturnCumulative with dividends | -96.6% | -100.0% | +102.5% | +58.5% | +36.1% |
| 10-Year ReturnCumulative with dividends | -97.4% | -100.0% | +435.6% | +112.9% | +323.5% |
| CAGR (3Y)Annualised 3-year return | -51.6% | -84.8% | +33.0% | +12.0% | +25.9% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than NCRA's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 96.1% from its 52-week high vs RELI's 6.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.68x | 1.35x | 0.95x | -0.15x | 0.89x |
| 52-Week HighHighest price in past year | $2.40 | $3.55 | $337.25 | $82.66 | $57.55 |
| 52-Week LowLowest price in past year | $0.16 | $0.15 | $260.31 | $65.35 | $43.66 |
| % of 52W HighCurrent price vs 52-week peak | +7.0% | +6.9% | +92.6% | +96.1% | +93.5% |
| RSI (14)Momentum oscillator 0–100 | 40.8 | 42.9 | 58.4 | 37.7 | 65.4 |
| Avg Volume (50D)Average daily shares traded | 7.2M | 2.9M | 7.1M | 12.7M | 32.4M |
Analyst Outlook
KO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JPM as "Buy", KO as "Buy", BAC as "Buy". Consensus price targets imply 13.6% upside for BAC (target: $61) vs 8.5% for JPM (target: $339). For income investors, KO offers the higher dividend yield at 2.56% vs JPM's 1.64%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $338.78 | $86.29 | $61.13 |
| # AnalystsCovering analysts | — | — | 61 | 48 | 54 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.6% | +2.6% | +2.4% |
| Dividend StreakConsecutive years of raises | — | 0 | 15 | 56 | 12 |
| Dividend / ShareAnnual DPS | — | — | $5.13 | $2.04 | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.4% | +0.2% | +5.2% |
KO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BAC leads in 1 (Valuation Metrics).
NCRA vs RELI vs JPM vs KO vs BAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NCRA or RELI or JPM or KO or BAC a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 14. 6% revenue growth year-over-year, versus -35. 2% for Nocera, Inc. (NCRA). Bank of America Corporation (BAC) offers the better valuation at 14. 1x trailing P/E (12. 1x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NCRA or RELI or JPM or KO or BAC?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
1x versus The Coca-Cola Company at 26. 1x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank of America Corporation wins at 0. 79x versus The Coca-Cola Company's 2. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NCRA or RELI or JPM or KO or BAC?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +102. 5%, compared to -100. 0% for Reliance Global Group, Inc. (RELI). Over 10 years, the gap is even starker: JPM returned +435. 6% versus RELI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NCRA or RELI or JPM or KO or BAC?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
15β versus Nocera, Inc. 's 1. 68β — meaning NCRA is approximately -1234% more volatile than KO relative to the S&P 500. On balance sheet safety, Bank of America Corporation (BAC) carries a lower debt/equity ratio of 121% versus 4% for Reliance Global Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NCRA or RELI or JPM or KO or BAC?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 14. 6% versus -35. 2% for Nocera, Inc. (NCRA). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -11. 1% for Nocera, Inc.. Over a 3-year CAGR, RELI leads at 13. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NCRA or RELI or JPM or KO or BAC?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus -64. 5% for Reliance Global Group, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -54. 8% for RELI. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NCRA or RELI or JPM or KO or BAC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bank of America Corporation (BAC) is the more undervalued stock at a PEG of 0. 79x versus The Coca-Cola Company's 2. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 1x forward P/E versus 24. 3x for The Coca-Cola Company — 12. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BAC: 13. 6% to $61. 13.
08Which pays a better dividend — NCRA or RELI or JPM or KO or BAC?
In this comparison, KO (2.
6% yield), BAC (2. 4% yield), JPM (1. 6% yield) pay a dividend. NCRA, RELI do not pay a meaningful dividend and should not be held primarily for income.
09Is NCRA or RELI or JPM or KO or BAC better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 6% yield, +112. 9% 10Y return). Nocera, Inc. (NCRA) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +112. 9%, NCRA: -97. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NCRA and RELI and JPM and KO and BAC?
These companies operate in different sectors (NCRA (Consumer Defensive) and RELI (Financial Services) and JPM (Financial Services) and KO (Consumer Defensive) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NCRA is a small-cap quality compounder stock; RELI is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; KO is a large-cap quality compounder stock; BAC is a large-cap deep-value stock. JPM, KO, BAC pay a dividend while NCRA, RELI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.